Search Results - "Ghosh, Sharmila B."

Real world predictors of response and 24-month survival in high-grade TP53-mutated myeloid neoplasms by Kaur, Amandeep, Rojek, Alexandra E., Symes, Emily, Nawas, Mariam T., Patel, Anand A., Patel, Jay L., Sojitra, Payal, Aqil, Barina, Sukhanova, Madina, McNerney, Megan E., Wu, Leo P., Akmatbekov, Aibek, Segal, Jeremy, Tjota, Melissa Y., Gurbuxani, Sandeep, Cheng, Jason X., Yeon, Su-Yeon, Ravisankar, Harini V., Fitzpatrick, Carrie, Lager, Angela, Drazer, Michael W., Saygin, Caner, Wanjari, Pankhuri, Katsonis, Panagiotis, Lichtarge, Olivier, Churpek, Jane E., Ghosh, Sharmila B., Patel, Ami B., Menon, Madhu P., Arber, Daniel A., Wang, Peng, Venkataraman, Girish

“…Current therapies for high-grade TP53 -mutated myeloid neoplasms (≥10% blasts) do not offer a meaningful survival benefit except allogeneic stem cell…”
Get full text

DDX41-Associated Myeloid Neoplasms by Qadir, Hira, Shen, Yulei, Liu, Wei, Gomez-Gelvez, Juan, Inamdar, Kedar V, Ghosh, Sharmila B

Get full text